EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Pharmacological Dose of Liraglutide Improves Mitochondrial Performance in Mouse Leydig Cells

Bruno Oliveira-Lopes iD, Patrícia C Braga iD, Pedro F Oliveira iD, Marco G Alves iD, Raquel L Bernardino

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26188903 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Bruno Oliveira-Lopes und 4 weiteren Autor:innen. Beteiligte Einrichtung: Unit for Multidisciplinary Research in Biomedicine (UMIB), School of Medicine and Biomedical Sciences (ICBAS), University of Porto, 4050-313 Porto, P…. Hauptthemen laut MEDLINE: Leydig Cells, Liraglutide, Mitochondria, Hypoglycemic Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, Fundação para a Ciência e a Tecnologia, Laboratory for Integrative and Translational Research in Population Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Male fertility has declined over the years, partly due to metabolic disorders such as obesity and Type 2 diabetes. Antidiabetic drugs, including GLP-1 receptor agonists like liraglutide, are widely used to manage these conditions and aid in weight loss. Within the male reproductive tract, Leydig cells (LCs) are essential since they produce testosterone. Notably, the influence of antidiabetics on LCs remains a subject of limited investigation. Herein, we aimed to evaluate the effect of liraglutide on the physiology of LCs. To this end, we cultured LCs (BLTK1 cell line) without (control) or in the presence of selected concentrations of liraglutide. We then assessed their metabolic viability, cell proliferation, LDH release, ROS production, mitochondrial membrane potential, and in vivo mitochondrial cell performance, as well as the number of mtDNA copies. We also measured androstenedione production. Our results showed that liraglutide at pharmacological and supra-pharmacological concentrations increased the metabolic viability of LCs and reduced ROS production at all concentrations. Furthermore, the pharmacological concentration of liraglutide increased the basal respiration, maximal respiration, proton leak, and oxygen consumption rate related to ATP-linked production. Androstenedione production remained unchanged, which may be related to the inherent limitations of the cell line in supporting steroidogenesis. Overall, our findings suggest that liraglutide exhibits a potential protective effect on LC function, particularly by enhancing metabolic viability, reducing oxidative stress, and improving mitochondrial performance, highlighting its potential beyond the established role in diabetes and weight management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leydig CellsLiraglutideMitochondriaHypoglycemic AgentsAnimalsMaleMiceMembrane Potential, MitochondrialReactive Oxygen SpeciesCell SurvivalCell LineCell ProliferationTestosterone

Stichwörter der Autor:innen

Leydig cellsliraglutidemale infertilitymetabolic disordersmitochondrial functionsteroidogenesis

Substanzen

LiraglutideReactive Oxygen SpeciesHypoglycemic AgentsTestosterone

Autor:innen und Institutionen

  • Unit for Multidisciplinary Research in Biomedicine (UMIB), School of Medicine and Biomedical Sciences (ICBAS), University of Porto, 4050-313 Porto, Portugal.
  • Laboratory for Integrative and Translational Research in Population Health (ITR), 4050-600 Porto, Portugal.
  • LAQV-REQUIMTE and Department of Chemistry, University of Aveiro, 3010-193 Aveiro, Portugal.
  • Institute of Biomedicine (iBiMED), Department of Medical Sciences, University of Aveiro, 3810-193 Aveiro, Portugal.

ORCID-Profile: Bruno Oliveira-Lopes, Patrícia C Braga, Pedro F Oliveira, Marco G Alves

Förderung

  • Fundação para a Ciência e Tecnologia
  • Fundação para a Ciência e a Tecnologia
  • Laboratory for Integrative and Translational Research in Population Health
  • Associated Laboratory for Green Chemistry
  • Patrícia Crespo Braga
  • European Regional Development Fund
  • COMPETE 2020

Zitieren

APA

Oliveira-Lopes, B., Braga, P. C., Oliveira, P. F., Alves, M. G., & Bernardino, R. L. (2025). A Pharmacological Dose of Liraglutide Improves Mitochondrial Performance in Mouse Leydig Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26188903

Vancouver

Oliveira-Lopes B, Braga PC, Oliveira PF, Alves MG, Bernardino RL. A Pharmacological Dose of Liraglutide Improves Mitochondrial Performance in Mouse Leydig Cells. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26188903

BibTeX
@article{OliveiraLopes2025,
  author = {Oliveira-Lopes, Bruno and Braga, Patrícia C and Oliveira, Pedro F and Alves, Marco G and Bernardino, Raquel L},
  title = {A Pharmacological Dose of Liraglutide Improves Mitochondrial Performance in Mouse Leydig Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26188903}
}
Kostenlos starten →